From August 1 to August 24, 2026, the company acquired 22,100 ordinary shares through market purchases for a total of 24,938,400 yen, and reported that the previously announced limit of 430,000 shares and 520,000,000 yen decided by the Board on March 27, 2026 has been completed and the acquisitions have ended.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"5187","jir_company_name":"Create Medic Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-08-25","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/08\/5187-20260825-01.pdf","jir_short_summary":"From August 1 to August 24, 2026, the company acquired 22,100 ordinary shares through market purchases for a total of 24,938,400 yen, and reported that the previously announced limit of 430,000 shares and 520,000,000 yen decided by the Board on March 27, 2026 has been completed and the acquisitions have ended.","jir_summary":"### Key points of the share buyback\nCreate Medic acquired its ordinary shares through market purchases during the period from August 1 to August 24, 2026. The total number of acquired shares is 22,100, and the total amount is 24,938,400 yen. These proceedings were conducted within the framework of up to 430,000 shares and up to 520,000,000 yen as resolved by the Board on March 27, 2026, and acquisition has ended as of the period.\n\n### Background and outlook\nThis was conducted as part of the company's capital policy as a treasury stock acquisition, carried out via market purchases. The actual figure did not exceed the upper limit, and since a completion report has been released, no additional share buyback plan has been disclosed at this time. The impact on future capital policy or shareholder returns remains unknown as there are no other disclosures in this IR material.","jir_financial_highlights":"Total number of shares acquired: 22,100 \u682a (Unknown)\nTotal amount acquired: 24,938,400 \u5186 (Unknown)\nAcquisition period (cap): 430,000 \u682a\uff08\u4e0a\u9650\uff09 (No comparison with previous disclosure)","jir_category":"","jir_hashtags":"#CreateMedicShareAcquisition, #CompletionOfTreasuryStockAcquisition","jir_key_figures":"Total number of shares acquired: 22,100 shares (upper limit 430,000 shares)\nTotal amount acquired: 24,938,400 yen (upper limit 52,000,000,000 yen)\nAcquisition period: August 1, 2026 \u2013 August 24, 2026","jir_meta_title":"\u3010Create Medic\u3011Announcement of Completion of Treasury Stock Acquisition | August 2026","jir_meta_description":"Create Medic's ordinary share treasury stock acquisition conducted from August 1\u201324, 2026 ended with 22,100 shares and 24,938,400 yen. Reported within the framework of up to 430,000 shares and up to 520,000,000 yen.","jir_og_title":"\u3010Create Medic\u3011Announcement of Completion of Treasury Stock Acquisition | August 2026","jir_og_description":"During the acquisition period, 22,100 shares were acquired for 24,938,400 yen, with an upper limit of 430,000 shares and 520,000,000 yen. Notification of completion.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":59045,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"share_buyback","footnotes":""},"sector":[],"importance":[],"class_list":["post-106860","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n